How to Turn a Poisonous Plant into Medicine: Non-Polar Extracts of Rhododendron adamsii (Sagan Dalya) Are Free of Grayanotoxins and Inhibit the SARS-CoV-2 Main Protease
Molecules · 2026
DOI: 10.3390/molecules31122090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Tatiana P Kukina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Plant Extracts, Rhododendron, SARS-CoV-2, Coronavirus 3C Proteases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The composition of low-polarity extracts obtained by sequential extraction of the aerial parts of Rhododendron adamsii Rehd. with hexane and methyl tert-butyl ether (MTBE) was investigated using GC-MS. The hexane extract was dominated by non-polar components: squalene, n-alkanes (nonacosane, hentriacontane), sesquiterpenes (trans-nerolidol, spathulenol, β-farnesene), and β-sitosterol. The subsequent MTBE extract was enriched in more polar lipids, primarily free triterpenic acids (ursolic and oleanolic acids). A critical finding was the complete absence of diterpene grayanotoxins in all tested extracts, confirming the safety of the non-polar extraction approach. In bioactivity assays, the total hexane extract demonstrated potent inhibitory activity against the SARS-CoV-2 main protease (3CLpro) with IC50 values of 0.0125–0.025 mg/mL, only one order of magnitude higher than the reference inhibitor disulfiram. Fractionation revealed that the activity was distributed among free acids, bound acids, and the unsaponifiable residue, indicating a multicomponent mechanism. Importantly, none of the samples inhibited HIV-1 protease (IC50 > 0.1 mg/mL), demonstrating selectivity for the cysteine protease 3CLpro over the aspartyl protease of HIV-1. These results highlight that sequential non-polar extraction of R. adamsii provides a grayanotoxin-free lipophilic complex with selective anti-SARS-CoV-2 protease activity, paving the way for bioactivity-guided identification of individual inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
- Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.
- State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Novosibirsk, Russia.
- Center for Recombinant Technologies, Altay State University, 656049 Barnaul, Russia.
ORCID-Profile: Svetlana V Belenkaya, Evgeniia A Kolosova, Dmitry N Shcherbakov
Förderung
- Russian Science Foundation
Zitieren
APA
Kukina, T. P., Elshin, I. A., Sal'nikova, O. I., Belenkaya, S. V., Kolosova, E. A., Volosnikova, E. A., Shchegolkova, V. O., & Shcherbakov, D. N. (2026). How to Turn a Poisonous Plant into Medicine: Non-Polar Extracts of Rhododendron adamsii (Sagan Dalya) Are Free of Grayanotoxins and Inhibit the SARS-CoV-2 Main Protease. Molecules. https://doi.org/10.3390/molecules31122090
Vancouver
Kukina TP, Elshin IA, Sal'nikova OI, Belenkaya SV, Kolosova EA, Volosnikova EA, et al. How to Turn a Poisonous Plant into Medicine: Non-Polar Extracts of Rhododendron adamsii (Sagan Dalya) Are Free of Grayanotoxins and Inhibit the SARS-CoV-2 Main Protease. Molecules. 2026. doi:10.3390/molecules31122090
BibTeX
@article{Kukina2026,
author = {Kukina, Tatiana P and Elshin, Ivan A and Sal'nikova, Ol'ga I and Belenkaya, Svetlana V and Kolosova, Evgeniia A and Volosnikova, Ekaterina A and Shchegolkova, Victoria O and Shcherbakov, Dmitry N},
title = {How to Turn a Poisonous Plant into Medicine: Non-Polar Extracts of Rhododendron adamsii (Sagan Dalya) Are Free of Grayanotoxins and Inhibit the SARS-CoV-2 Main Protease},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31122090}
}
EUVIMED